CGON CG Oncology, Inc.

Fundamentals / CIK 0001991792 / USD

CG Oncology, Inc. reported $6.17M in revenue and a net loss of $237.5M for the trailing twelve months ended September 30, 2026 (down 3.7% year over year), with a -4293.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CGON in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$20.98M$10.49M$0-$150.9MFY 2023 Revenue: $204KFY 2023 Net Income: -$48.61M2023FY 2024 Revenue: $1.14MFY 2024 Net Income: -$88.04M2024FY 2025 Revenue: $4.04MFY 2025 Net Income: -$161.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $4.04M $1.14M $204K
Research & Development $116.6M $82.10M $45.75M
Total Operating Expenses -- $115.8M $55.65M
Operating Income -$190.8M -$114.7M -$55.45M
EBITDA -$189.3M -$114.6M -$55.43M
Interest Income $29.93M $26.62M $6.90M
Income Tax Expense -$270K $1.0K $1.0K
Net Income -$161.0M -$88.04M -$48.61M
Basic EPS -$2.08 -$1.41 -$15.65
Diluted EPS -$2.08 -$1.41 -$15.65
Basic Shares Outstanding 77.3M 62.5M 4.3M
Diluted Shares Outstanding 77.3M 62.5M 4.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.60M $1.16M $1.08M $2.32M $1.67M $0 $52K $456K
Cost of Revenue $2.67M -- -- -- $1.58M -- -- --
Gross Profit -$1.06M -- -- -- $89K -- -- --
Research & Development $39.22M $54.66M $43.73M $29.96M $27.88M $31.33M $27.47M $26.80M
Total Operating Expenses -- -- -- -- -- $48.74M $42.26M $38.51M
Operating Income -$63.25M -$86.40M -$66.39M -$48.70M -$51.13M -$48.74M -$42.20M -$38.05M
EBITDA -$62.09M -$85.55M -$65.55M -$47.85M -$50.71M -$48.59M -$42.18M -$38.05M
Interest Income $6.42M $7.33M $6.29M $7.44M $7.42M $7.32M $7.75M $6.25M
Net Income -$56.89M -$79.06M -$60.20M -$41.31M -$43.81M -$41.43M -$34.45M -$31.80M
Basic EPS -$0.64 -$0.90 -$0.71 -- -$0.57 -$0.54 -$0.45 --
Diluted EPS -$0.64 -$0.90 -$0.71 -- -$0.57 -$0.54 -$0.45 --
Basic Shares Outstanding 88.9M 88.2M 84.5M -- 76.7M 76.2M 76.2M --
Diluted Shares Outstanding 88.9M 88.2M 84.5M -- 76.7M 76.2M 76.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $32.49M $257.1M $8.27M
Short-Term Investments $709.7M $484.9M $179.4M
Cash & Short-Term Investments $742.2M $742.0M $187.7M
Accounts Receivable, Net $688K $0 --
Inventory $1.56M $0 --
Total Current Assets $759.5M $754.2M $194.1M
Property, Plant & Equipment, Net $15.60M $272K $69K
Goodwill $10.30M $0 --
Intangible Assets $575K $0 --
Other Non-Current Assets $1.68M $94K $19K
Total Non-Current Assets $32.12M $587K $5.18M
Total Assets $791.6M $754.8M $199.3M
Accounts Payable $5.71M $6.52M $3.24M
Deferred Revenue (Current) $286K -- --
Total Current Liabilities $30.84M $21.37M $14.25M
Long-Term Debt $3.00M $0 --
Other Non-Current Liabilities $1.74M $0 --
Total Non-Current Liabilities $8.15M $52K $257K
Total Liabilities $38.99M $21.42M $14.51M
Total Debt (incl. Leases) $7.02M $238K $461K
Common Stock $8.0K $8.0K --
Retained Earnings -$379.0M -$218.0M -$129.9M
Total Stockholders' Equity $752.6M $733.4M -$123.1M
Total Equity $752.6M $733.4M -$123.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $28.25M $19.64M $33.70M $32.49M $45.15M $14.62M $41.47M $257.1M
Short-Term Investments $956.2M $1.01B $1.04B $709.7M $635.1M $646.4M $647.0M $484.9M
Cash & Short-Term Investments $984.5M $1.03B $1.08B $742.2M $680.3M $661.1M $688.4M $742.0M
Accounts Receivable, Net $666K $417K $1.27M $688K $515K -- -- $0
Inventory $1.17M $1.00M $1.49M $1.56M $1.50M -- -- $0
Total Current Assets $1.01B $1.05B $1.10B $759.5M $695.8M $673.0M $701.2M $754.2M
Property, Plant & Equipment, Net $14.93M $14.71M $15.07M $15.60M $15.33M $253K $264K $272K
Goodwill $10.30M $10.30M $10.30M $10.30M $12.80M -- -- $0
Intangible Assets $530K $545K $560K $575K $1.67M -- -- $0
Other Non-Current Assets $6.92M $4.73M $2.68M $1.68M $114K $522K $516K $94K
Total Non-Current Assets $38.94M $36.01M $33.12M $32.12M $34.12M $28.41M $26.99M $587K
Total Assets $1.05B $1.09B $1.14B $791.6M $729.9M $701.4M $728.2M $754.8M
Accounts Payable $9.77M $12.73M $8.24M $5.71M $9.19M $7.12M $6.73M $6.52M
Deferred Revenue (Current) $29K -- -- $286K -- -- -- --
Total Current Liabilities $46.43M $47.24M $35.22M $30.84M $30.53M $30.38M $22.64M $21.37M
Long-Term Debt $3.00M $3.00M $3.00M $3.00M $3.00M -- -- $0
Other Non-Current Liabilities $855K $1.16M $1.45M $1.74M $3.80M -- -- $0
Total Non-Current Liabilities $9.27M $9.30M $8.27M $8.15M $11.74M $706K $781K $52K
Total Liabilities $55.70M $56.54M $43.48M $38.99M $42.27M $31.09M $23.42M $21.42M
Total Debt (incl. Leases) $9.24M $8.82M $7.58M $7.02M $7.24M $994K $1.04M $238K
Common Stock $9.0K $9.0K $9.0K $8.0K $8.0K $8.0K $8.0K $8.0K
Retained Earnings -$575.1M -$518.2M -$439.2M -$379.0M -$337.7M -$293.9M -$252.4M -$218.0M
Total Stockholders' Equity $991.0M $1.03B $1.09B $752.6M $687.6M $670.4M $704.8M $733.4M
Total Equity $991.0M $1.03B $1.09B $752.6M $687.6M $670.4M $704.8M $733.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$161.0M -$88.04M -$48.61M
Depreciation & Amortization $1.45M $32K $17K
Stock-Based Compensation $26.68M $11.40M $1.53M
Change in Receivables -$320K -- --
Change in Inventory -$444K -- --
Change in Payables -$1.64M $3.27M $2.01M
Operating Cash Flow -$132.3M -$78.71M -$45.68M
Capital Expenditure -$134K -$234K --
Free Cash Flow -$132.5M -$78.95M --
Acquisitions, Net -$21.97M -- --
Purchases of Investments -$1.07B -$1.05B -$517.6M
Sales & Maturities of Investments $844.1M $745.4M $396.4M
Investing Cash Flow -$245.8M -$300.8M -$121.2M
Common Stock Issued $147.4M $223.1M --
Financing Cash Flow $153.6M $628.3M $87.00M
Net Change in Cash -$224.6M $248.8M -$79.88M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$56.89M -$79.06M -$60.20M -$41.31M -$43.81M -$41.43M -$34.45M -$31.80M
Depreciation & Amortization $1.16M $850K $841K $849K $416K $156K $24K $0
Stock-Based Compensation $8.46M $14.33M $6.47M $7.19M $7.33M $7.01M $5.15M $4.99M
Change in Receivables -$249K $858K -$587K -- -- -- -- --
Change in Inventory -$162K $490K $72K -- -- -- -- --
Change in Payables -$2.96M $4.49M $2.52M -$3.48M $1.23M $394K $214K $2.44M
Operating Cash Flow -$47.71M -$46.41M -$56.94M -$36.22M -$38.89M -$27.96M -$29.28M -$20.66M
Capital Expenditure -$1.11M -$468K -$304K -$7.0K -$97K -$14K -$16K -$209K
Free Cash Flow -$48.82M -$46.88M -$57.25M -$36.22M -$38.99M -$27.97M -$29.29M -$20.87M
Purchases of Investments -- -$196.0M -$587.4M -$297.7M -$240.3M -$168.0M -$361.9M --
Sales & Maturities of Investments $169.7M $226.9M $252.9M $222.2M $251.4M $170.4M $200.1M --
Investing Cash Flow $46.03M $30.43M -$334.8M -$75.50M $15.04M $1.41M -$186.8M $10.90M
Common Stock Issued $0 $0 $391.6M -- -- -- -- --
Financing Cash Flow $10.28M $1.92M $393.0M $99.07M $54.37M -$296K $450K $223.4M
Net Change in Cash $8.61M -$14.06M $1.21M -$12.65M $30.52M -$26.85M -$215.6M $213.7M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -4722.1% -10067.3% -27180.9%
Net Profit Margin -3985.0% -7729.5% -23827.0%
Return on Equity (ROE) -21.4% -12.0% --
Return on Assets (ROA) -20.3% -11.7% -24.4%
Current Ratio 24.63x 35.30x 13.62x
Quick Ratio 24.58x 35.30x 13.17x
Debt to Equity 0.01x 0.00x --
Revenue Growth (YoY) +254.7% +458.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -4293.5% -4056.2% -4239.0% -4722.1% -8285.3% -28546.1% -20302.3% -10067.3%
Net Profit Margin -3851.1% -3602.7% -3682.6% -3985.0% -6968.0% -23245.2% -15945.2% -7729.5%
Return on Equity (ROE) -24.0% -21.8% -17.1% -21.4% -22.0% -19.1% -15.0% -12.0%
Return on Assets (ROA) -22.7% -20.7% -16.4% -20.3% -20.8% -18.3% -14.5% -11.7%
Current Ratio 21.70x 22.22x 31.30x 24.63x 22.79x 22.15x 30.97x 35.30x
Quick Ratio 21.68x 22.20x 31.25x 24.58x 22.74x 21.76x 30.41x 35.30x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -3.7% -- +1982.7% +409.2% +3774.4% -100.0% -90.2% +45500.0%
Gross Profit Growth (YoY) -1296.6% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001991792) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:13 UTC · Open in terminal